Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$206.08
-1.6%
$198.27
$153.58
$218.66
$364.55B0.615.73 million shs7.85 million shs
The Coca-Cola Company stock logo
KO
Coca-Cola
$71.85
+0.3%
$67.95
$57.93
$73.53
$309.21B0.5714.93 million shs15.30 million shs
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
$560.97
+0.3%
$588.00
$493.86
$613.23
$594.63B1.0152.75 million shs54.33 million shs
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$45.38
+0.0%
$42.24
$37.59
$47.36
$191.02B0.4119.53 million shs15.71 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+2.30%+0.28%+0.36%+18.08%+15.23%
The Coca-Cola Company stock logo
KO
Coca-Cola
+1.88%+3.94%+0.69%+15.14%+17.17%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
+0.67%-2.56%-5.86%-4.55%+6.94%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
+0.98%+4.16%+5.29%+13.52%+8.19%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.5219 of 5 stars
2.53.03.33.93.52.51.3
The Coca-Cola Company stock logo
KO
Coca-Cola
4.1203 of 5 stars
2.53.03.30.83.42.51.3
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/AN/AN/AN/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
4.7123 of 5 stars
2.33.05.03.53.52.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.92
Moderate Buy$211.452.61% Upside
The Coca-Cola Company stock logo
KO
Coca-Cola
3.00
Buy$74.243.32% Upside
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
2.78
Moderate Buy$560.97N/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
2.56
Moderate Buy$46.823.19% Upside

Current Analyst Ratings Breakdown

Latest SPY, VZ, ABBV, and KO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$48.00 ➝ $50.00
3/25/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$42.00 ➝ $45.00
3/17/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/12/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
3/5/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$210.00 ➝ $240.00
3/4/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$200.00 ➝ $223.00
3/3/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$47.50 ➝ $48.00
2/28/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$73.00 ➝ $80.00
2/13/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$66.00 ➝ $73.00
2/13/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$75.00
2/12/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$72.00 ➝ $78.00
(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B6.47$15.23 per share13.53$1.90 per share108.46
The Coca-Cola Company stock logo
KO
Coca-Cola
$47.06B6.57$3.22 per share22.29$6.12 per share11.74
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/AN/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$134.79B1.42$9.45 per share4.80$23.89 per share1.90
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.4085.8714.741.627.59%296.28%12.65%4/25/2025 (Estimated)
The Coca-Cola Company stock logo
KO
Coca-Cola
$10.63B$2.4729.0922.523.7922.59%45.37%12.24%4/29/2025 (Estimated)
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/A24.79N/AN/AN/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$17.51B$4.1410.969.344.4512.99%19.80%5.08%4/28/2025 (Estimated)

Latest SPY, VZ, ABBV, and KO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2025N/A
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.72N/AN/AN/A$11.23 billionN/A
4/28/2025N/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$1.15N/AN/AN/AN/AN/A
4/25/2025N/A
AbbVie Inc. stock logo
ABBV
AbbVie
$2.51N/AN/AN/A$12.91 billionN/A
2/11/2025Q4 2024
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.51$0.55+$0.04$0.51$10.70 billionN/A
1/31/2025Q4 24
AbbVie Inc. stock logo
ABBV
AbbVie
$2.98$2.16-$0.82-$0.02$14.81 billionN/A
1/24/2025Q4 2024
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$1.11$1.10-$0.01$1.19$35.49 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.563.18%+6.04%273.33%53 Years
The Coca-Cola Company stock logo
KO
Coca-Cola
$2.042.84%+4.91%82.59%64 Years
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
$7.171.28%N/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$2.715.97%+1.93%65.46%20 Years

Latest SPY, VZ, ABBV, and KO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/13/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.643.4%4/15/20254/15/20255/15/2025
2/28/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
quarterly$0.67756.29%4/10/20254/10/20255/1/2025
2/20/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
quarterly$0.512.9%3/14/20253/14/20254/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
17.94
0.66
0.55
The Coca-Cola Company stock logo
KO
Coca-Cola
1.61
1.03
0.84
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/AN/AN/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
1.21
0.63
0.59

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
The Coca-Cola Company stock logo
KO
Coca-Cola
70.26%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
63.54%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
62.06%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
The Coca-Cola Company stock logo
KO
Coca-Cola
0.97%
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/A
Verizon Communications Inc. stock logo
VZ
Verizon Communications
0.02%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.76 billionOptionable
The Coca-Cola Company stock logo
KO
Coca-Cola
82,5004.30 billion4.27 billionOptionable
SPDR S&P 500 ETF Trust stock logo
SPY
SPDR S&P 500 ETF Trust
N/A1.06 billionN/ANot Optionable
Verizon Communications Inc. stock logo
VZ
Verizon Communications
117,1004.21 billion4.21 billionOptionable

Recent News About These Companies

Verizon Communications Inc DRC (VZm)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$206.08 -3.44 (-1.64%)
Closing price 03:59 PM Eastern
Extended Trading
$206.78 +0.70 (+0.34%)
As of 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Coca-Cola stock logo

Coca-Cola NYSE:KO

$71.85 +0.23 (+0.32%)
Closing price 03:59 PM Eastern
Extended Trading
$71.86 +0.01 (+0.01%)
As of 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

SPDR S&P 500 ETF Trust stock logo

SPDR S&P 500 ETF Trust NYSEARCA:SPY

$560.97 +1.58 (+0.28%)
Closing price 04:10 PM Eastern
Extended Trading
$562.39 +1.42 (+0.25%)
As of 06:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SPDR S&P 500 ETF Trust (the Trust) is a unit investment trust. The Trust seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index (the Index). The Trust seeks to achieve this investment objective by holding a portfolio of the common stocks that are included in the Index (the Portfolio), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the Index. The Trust invests in a range of sectors, including pharmaceuticals; oil, gas and consumable fuels; technology hardware storage and peripherals; insurance; information technology (IT) services; healthcare providers and services; semiconductors and semiconductor equipment; hotels, restaurants and leisure, communications equipment; commercial services and supplies; road and rail; real estate management and development; containers and packaging; professional services, and paper and forest products.

Verizon Communications stock logo

Verizon Communications NYSE:VZ

$45.38 +0.02 (+0.03%)
Closing price 03:59 PM Eastern
Extended Trading
$45.40 +0.02 (+0.06%)
As of 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks, as well as related equipment and devices, such as smartphones, tablets, smart watches, and other wireless-enabled connected devices. The segment also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including FWA broadband, data, video and conferencing, corporate networking, security and managed network, local and long-distance voice, and network access services to deliver various IoT services and products to businesses, government customers, and wireless and wireline carriers in the United States and internationally. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.